1. Home
  2. Live Updates
  3. Thromb haemost

Live Breaking News & Updates on Thromb haemost

Stay informed with the latest breaking news from Thromb haemost on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Thromb haemost and stay connected to the pulse of your community

U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B

A one-time dose of BEQVEZ has reduced bleeds post-treatment compared to standard of care with a median of zero bleeds after up to three years of follow-up, providing sustained bleed protection and...

United-states , Canada , Adam-cuker , Thromb-haemost , Kim-phelan , Aamir-malik , Drug-administration , Linkedin , Pfizer-inc , Hemophilia-thrombosis-program , Facebook , Pfizer

Open Strategic Autonomy for plasma therapies in the EU

Open Strategic Autonomy for plasma therapies in the EU
politico.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.eu Daily Mail and Mail on Sunday newspapers.

Bunschoten , Utrecht , Netherlands , J-thromb-haemost , Eu-critical-medicines-alliance , National-hemophilia-foundation , Elsevier-health-sciences , Plasma-protein-therapeutics-association , Strategic-autonomy , Human-origin , General-pharmaceutical-legislation , Medicines-alliance

Anthos Therapeutics Announces Appointment of Bill Meury as CEO

Anthos Therapeutics Announces Appointment of Bill Meury as CEO
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , Canada , America , John-glasspool , Nicholas-galakatos , Bristol-myers-squibb , Thromb-haemost , David-gailani , Andras-gruber

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

cTTP is an Ultra-rare Blood Clotting Disorder Associated with Life-Threatening Acute Events and Debilitating Chronic Symptoms



ADZYNMA is the First and Only Recombinant ADAMTS13 Enzyme...

United-states , Japan , Japanese , Yasushi-kajii , Thromb-haemost , Kremer-hovinga , Van-dorland , European-medicines-agency , Japan-ministry-of-health , Takeda-pharmaceutical-company-limited , Exchange-commission , Drug-administration

Thrombotic Adverse Events Frequent After Emicizumab for Hemophilia A

An analysis of an FDA adverse event database found thrombotic adverse events were more frequently reported with emicizumab than those of FVIII products.

Thromb-haemost , Shimam-emicizumab , J-thromb-haemost , Bongkyoo-choi , Healthy-work-campaign-bongkyoo-choi , Drug-administration , Healthy-work-campaign , Adverse-event-reporting-system ,

Targeted prophylactic anticoagulation based on the TRiP(cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised implementation trial

Targeted prophylactic anticoagulation based on the TRiP(cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised implementation trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Douillet , Pays-de-la-loire , France , French , Hylckama-vlieg , Mal-respir , Thromb-haemost , J-thromb-haemost , European-respiratory-society , French-society-of-anaesthesia , American-college-of-chest-physicians-evidence , Guidelines-in-emergency-medicine-network-gemnet

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders

Showcasing wilate® at EAHAD 2024WIL-31 is the largest prospective prophylaxis study in VWD with an on-demand run-in study as an intra-individual patient ...

Germany , Zagreb , Grad , Croatia , Antara , Aceh , Indonesia , Austria , Lachen , Switzerland-general- , Switzerland , France

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

LACHEN, Switzerland, Jan. 18, 2024 /PRNewswire/ --

Thailand , France , Austria , Sweden , Lachen , Switzerland-general- , Switzerland , Zagreb , Grad , Croatia , Germany , Willebrand

Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 12, 2023--

United-states , Cambridge , Cambridgeshire , United-kingdom , Canada , Massachusetts , Americans , America , American , Coll-cardiol , Thromb-haemost , Dan-bloomfield

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.

United-states , Louisiana , North-dakota , Greene , Minnesota , New-york , California , New-orleans , Olmsted-county , Lawrenceville , American , Americans